NON-NEOVASCULAR AMD

Clinical trials for NON-NEOVASCULAR AMD explained in plain language.

Never miss a new study

Get alerted when new NON-NEOVASCULAR AMD trials appear

Sign up with your email to follow new studies for NON-NEOVASCULAR AMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental eye injection aims to halt vision loss in dry AMD

Disease control Recruiting now

This early-stage study is testing whether a single injection called VOY-101 can slow the progression of advanced dry age-related macular degeneration (AMD), a condition that causes gradual central vision loss. Researchers will give increasing doses to 60 participants aged 60+ to …

Matched conditions: NON-NEOVASCULAR AMD

Phase: PHASE1, PHASE2 • Sponsor: Perceive Biotherapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

NON-NEOVASCULAR AMD

Get alerted when new NON-NEOVASCULAR AMD trials appear

Experimental eye injection aims to halt vision loss in dry AMD